期刊
ORGANIC PROCESS RESEARCH & DEVELOPMENT
卷 23, 期 11, 页码 2464-2469出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.oprd.9b00353
关键词
CD4-mimetic; HIV-1 entry inhibitor; dynamic-kinetic resolution; guanidine formation; aminolysis; Gabriel amine synthesis
资金
- National Institutes of Health [P01 NIH/NIGMS GM56550/AI150471, RO1 AJ134494, TaPHIR R21 AI129017-01]
- GILEAD, HIV Cure Program
- amfAR, The Foundation for AIDS Research [109343-59-RGRL]
We report here the development and optimization of a process synthesis for the human immunodeficiency virus-1 entry inhibitor BNM-III-170 bis-trifluoroacetate salt (1). The synthesis features a dynamic-kinetic resolution to establish the initial stereogenicity. By taking advantage of significant sequence modifications of our first-generation synthesis, in conjunction with the low solubility of late-stage intermediates, the overall efficiency of the synthesis has been significantly improved, now to proceed in an overall yield of 9.64% for the 16 steps, requiring only a single chromatographic separation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据